📰 Genentech News
Page 39 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
February 16, 2024
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday. Xolair, the brand name for the drug omalizumab, became the first medication approved to reduce allergic reactions caused by accidental exposure to food triggers. Patients as young as […]
February 16, 2024
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday.
February 16, 2024
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday.
February 16, 2024
The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods.
February 16, 2024
The new indication makes Xolair (omalizumab) the first drug approved to mitigate allergic reactions to more than one food.
February 16, 2024
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions
February 16, 2024
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday.
February 16, 2024
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday.
February 16, 2024
68% of patients who received omalizumab tolerated a single dose of peanut after 16-20 weeks
February 16, 2024
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions.